Finland · research
Finland · researchStemSight
StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.
PrivateFor profit
Against its peers
Set against 3,254 research companies worldwide. The ring marks the typical peer.
Across all 5.9M companies: larger than 0% of those with a size listed; older than 0% of those with a founding year; website ranked #16,086,816 in the world, about 1 visits a month.
About StemSight
BiotechnologyHealth DiagnosticsTherapeutics
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$2.4M
raised in total, currency not stated across 1 round
Last raised Sept 2021, 5 years ago
- Rounds
- 1
- Latest round
- Seed
- Investors
- 22 leading
Key facts
Who started it and how it trades.
- Founded by
- Heli Skottman, Laura Koivusalo
Every detail we hold
Everything the source datasets list about StemSight, field by field. Contact details are held but never shown.
The company7 fields
- Name
- StemSight
- Type
- For profit
- Status
- Private
- Founded
- 2021
- Founders
- Heli Skottman, Laura Koivusalo
- Industry
- research
- Categories
- Biotechnology, Health Diagnostics, Therapeutics
Where3 fields
- City
- Tampere
- Country
- Finland
- Markets
- European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA)
Size and reach3 fields
- Staff band
- 1-10
- Web traffic rank
- #16,086,816
- Monthly web visits
- 1
Show 9 more fieldsShow fewer fields
Funding, as listed7 fields
- Total
- 2,395,130 (currency not stated)
- Rounds
- 1
- Latest round
- Seed
- Latest round date
- Sept 2021
- Investors
- 2
- Lead investors
- 2
- Listing status
- private
About this record2 fields
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
StemSight may be growing as it has engaged in a collaboration with ERS Genomics, which is a significant step in advancing its research and development capabilities. The partnership involves a CRISPR/Cas9 license agreement, indicating an expansion of StemSight's technological toolkit and potential enhancement of its product development pipeline. This strategic move suggests an investment in intellectual property and technology that could lead to the development of new treatments for blindness, aligning with the company's core focus in cell therapy.
Companies like StemSight
research in Finland.
VolareHelsinki · 1-10 peoplefounded the same year
AlgorithmiqMilano · 11-50 peoplefounded 1 years earlier
Valo TherapeuticsHelsinki · 11-50 peoplefounded 5 years earlier
Linio Biotech LtdHelsinki · 11-50 peoplefounded 4 years earlier
Rappta TherapeuticsHelsingfors · 11-50 peoplefounded 15 years earlier
FIT BiotechTampere · 11-50 peoplefounded 26 years earlierBuild a lead list
Every research company, filtered by size, age and reach, ready to export with emails on Pro.